JP2017532544A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532544A5 JP2017532544A5 JP2017513482A JP2017513482A JP2017532544A5 JP 2017532544 A5 JP2017532544 A5 JP 2017532544A5 JP 2017513482 A JP2017513482 A JP 2017513482A JP 2017513482 A JP2017513482 A JP 2017513482A JP 2017532544 A5 JP2017532544 A5 JP 2017532544A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- array
- antibody
- length
- celiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 34
- 102000004196 processed proteins & peptides Human genes 0.000 claims 27
- 229920001184 polypeptide Polymers 0.000 claims 23
- 238000000034 method Methods 0.000 claims 14
- 150000001413 amino acids Chemical class 0.000 claims 12
- 208000023275 Autoimmune disease Diseases 0.000 claims 10
- 230000035945 sensitivity Effects 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- 208000015943 Coeliac disease Diseases 0.000 claims 4
- 238000001514 detection method Methods 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 208000026278 immune system disease Diseases 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000000090 biomarker Substances 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 101710087459 Gamma-gliadin Proteins 0.000 claims 1
- 108010061711 Gliadin Proteins 0.000 claims 1
- 101710183587 Omega-gliadin Proteins 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000009257 reactivity Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- -1 β-gliadin Proteins 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021084301A JP7256229B2 (ja) | 2014-09-10 | 2021-05-19 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048537P | 2014-09-10 | 2014-09-10 | |
| US62/048,537 | 2014-09-10 | ||
| PCT/US2015/049528 WO2016040703A1 (en) | 2014-09-10 | 2015-09-10 | Peptide microarrays and novel biomarkers for celiac disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021084301A Division JP7256229B2 (ja) | 2014-09-10 | 2021-05-19 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532544A JP2017532544A (ja) | 2017-11-02 |
| JP2017532544A5 true JP2017532544A5 (enExample) | 2019-02-28 |
| JP6887945B2 JP6887945B2 (ja) | 2021-06-16 |
Family
ID=55459587
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017513482A Active JP6887945B2 (ja) | 2014-09-10 | 2015-09-10 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
| JP2021084301A Active JP7256229B2 (ja) | 2014-09-10 | 2021-05-19 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
| JP2023054447A Active JP7781813B2 (ja) | 2014-09-10 | 2023-03-30 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021084301A Active JP7256229B2 (ja) | 2014-09-10 | 2021-05-19 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
| JP2023054447A Active JP7781813B2 (ja) | 2014-09-10 | 2023-03-30 | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10900964B2 (enExample) |
| EP (1) | EP3191629A4 (enExample) |
| JP (3) | JP6887945B2 (enExample) |
| AU (3) | AU2015314934A1 (enExample) |
| CA (1) | CA2960655C (enExample) |
| NZ (1) | NZ730519A (enExample) |
| WO (1) | WO2016040703A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10900964B2 (en) | 2014-09-10 | 2021-01-26 | Vibrant Holdings, Llc | Peptide microarrays and novel biomarkers for celiac disease |
| US11033904B2 (en) | 2015-10-29 | 2021-06-15 | Vibrant Holdings, Llc | Methods, tools, and tool assemblies for biomolecular analysis using microarrays |
| EP3472181A4 (en) * | 2016-06-20 | 2020-05-13 | Healthtell Inc. | METHOD FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES |
| AU2017281039A1 (en) * | 2016-06-20 | 2019-01-24 | Healthtell Inc. | Methods for differential diagnosis of autoimmune diseases |
| EP3523657B1 (en) | 2016-10-04 | 2023-06-21 | F. Hoffmann-La Roche AG | System and method for identification of a synthetic classifier |
| CA3043264A1 (en) | 2016-11-11 | 2018-05-17 | Healthtell Inc. | Methods for identifying candidate biomarkers |
| CN107176974B (zh) * | 2017-06-06 | 2021-04-13 | 中国医学科学院北京协和医院 | ω-5-醇溶蛋白特异的CD4+T细胞表位及其应用 |
| EP3735481A4 (en) * | 2018-01-05 | 2021-08-11 | Centrillion Technology Holdings Corporation | METHODS OF MANUFACTURING A HIGH RESOLUTION DNA CHIP AND USING THE SAME IN SEQUENCING |
| US20210341493A1 (en) * | 2018-10-08 | 2021-11-04 | Vibrant Holdings Llc | tTG-DGP BIOMARKERS FOR MONITORING CELIAC DISEASE |
| CN111926051A (zh) * | 2020-07-10 | 2020-11-13 | 内蒙古燕谷坊全谷物产业发展有限责任公司 | 一种燕麦肽粉及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19630557C2 (de) | 1996-07-18 | 1998-07-02 | Schuppan Detlef Priv Doz Dr Dr | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie |
| EP1197755A1 (en) * | 2000-10-11 | 2002-04-17 | Pepscan Systems B.V. | Identification of protein binding sites |
| AU2002241504A1 (en) | 2000-11-13 | 2002-06-18 | Picoliter Inc. | Integrated device with surface-attached molecular moieties and related machine-readable information |
| JP2002320341A (ja) | 2001-02-14 | 2002-10-31 | Sony Corp | 充放電装置および方法、電力供給装置および方法、電力供給システムおよび方法、プログラム格納媒体、並びにプログラム |
| ATE509272T1 (de) | 2001-11-09 | 2011-05-15 | 3Dbiosurfaces Technologies Llc | Substrate mit hochliegendem oberflächenbereich für mikroarrays sowie verfahren zur herstellung davon |
| GB0212885D0 (en) * | 2002-06-05 | 2002-07-17 | Isis Innovation | Therapeutic epitopes and uses thereof |
| US7290169B2 (en) | 2004-04-06 | 2007-10-30 | Hewlett-Packard Development Company, L.P. | Core-level processor lockstepping |
| EP2318429B1 (en) | 2008-07-28 | 2016-04-20 | Children's Medical Center Corporation | Prominin-1 peptide fragments and uses thereof |
| US8835603B2 (en) * | 2008-11-30 | 2014-09-16 | Immusant, Inc. | Agents for the treatment of celiac disease |
| FR2949782B1 (fr) * | 2009-09-04 | 2015-10-16 | Isp Investments Inc | Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant. |
| JP6012767B2 (ja) | 2012-02-07 | 2016-10-25 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | 基板、ペプチドアレイ、および方法 |
| DE102013214247A1 (de) | 2013-07-22 | 2015-01-22 | Bayerische Motoren Werke Aktiengesellschaft | Blindnietmutter für die Verbindung zweier Bauteile |
| CN103675291A (zh) | 2013-11-25 | 2014-03-26 | 南昌大学 | 一种基于t细胞表位筛查低乳糜泻毒性小麦品种的方法 |
| US10900964B2 (en) | 2014-09-10 | 2021-01-26 | Vibrant Holdings, Llc | Peptide microarrays and novel biomarkers for celiac disease |
-
2015
- 2015-09-10 US US15/510,223 patent/US10900964B2/en active Active
- 2015-09-10 NZ NZ730519A patent/NZ730519A/en unknown
- 2015-09-10 CA CA2960655A patent/CA2960655C/en active Active
- 2015-09-10 EP EP15839169.8A patent/EP3191629A4/en active Pending
- 2015-09-10 AU AU2015314934A patent/AU2015314934A1/en not_active Abandoned
- 2015-09-10 WO PCT/US2015/049528 patent/WO2016040703A1/en not_active Ceased
- 2015-09-10 JP JP2017513482A patent/JP6887945B2/ja active Active
-
2019
- 2019-02-08 AU AU2019200921A patent/AU2019200921B2/en active Active
-
2020
- 2020-12-21 US US17/129,091 patent/US20210285948A1/en active Pending
-
2021
- 2021-05-19 JP JP2021084301A patent/JP7256229B2/ja active Active
- 2021-06-16 AU AU2021203987A patent/AU2021203987A1/en not_active Abandoned
-
2023
- 2023-03-30 JP JP2023054447A patent/JP7781813B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532544A5 (enExample) | ||
| EP3855186B1 (en) | A method for determining the efficacy of a sars-cov-2 vaccine | |
| Poole et al. | Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments | |
| JP2021167805A (ja) | ＳＡＲＳ−ＣｏＶ−２感染症を診断するための方法および試薬 | |
| Figura et al. | Cross-sectional study: CagA–positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide | |
| JP2015525208A5 (enExample) | ||
| Bottino et al. | Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay | |
| JP2016026303A5 (enExample) | ||
| JP2011523550A5 (enExample) | ||
| JP2007535912A5 (enExample) | ||
| WO2010052939A1 (ja) | アレルゲンのエピトープ又はその候補の検出方法及びその利用 | |
| CN112114150B (zh) | 用于诊断海鲜过敏的方法及产品 | |
| US20130296240A1 (en) | Pneumonia biomarkers | |
| Zhou et al. | Antibodies to peptides in semiconserved domains of RIFINs and STEVORs correlate with malaria exposure | |
| Kusi et al. | Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana | |
| JP2019531716A5 (enExample) | ||
| JP5042237B2 (ja) | 血小板抗原特異抗体の結合を中和するペプチドアプタマー並びにそれを含む診断及び治療への応用 | |
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| WO2006119527A2 (en) | Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use | |
| JP6122779B2 (ja) | 抗ｗｔ１抗体の測定方法 | |
| KR20130088845A (ko) | 인간 사이토메갈로 바이러스 감염의 검출 방법 | |
| JP2009517015A5 (enExample) | ||
| Pinilla et al. | Elucidation of monoclonal antibody polyspecificity using a synthetic combinatorial library. | |
| CN102775486A (zh) | 监测肾损伤的新型试剂和试剂盒 | |
| Stephenson et al. | Identification of host insulin binding sites on Schistosoma japonicum insulin receptors |